Clinical Trial

Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to evaluate the effectiveness of the computer-aided diagnosis (CADx) software, 'WAYMED endo CL CS', which assists medical specialists by automatically analyzing colorectal endoscopic images, identifying lesions, and providing probability values to classify them as Adenoma or Non-Adenoma. This pivotal trial is designed to confirm that 'WAYMED endo CL CS' can support clinicians in diagnostic decision-making by improving the classification of colorectal lesions.
Trial Details
NCT Number NCT07470827
Lead Sponsor WAYCEN Inc
Conditions Colorectal Adenoma, Sessile Serrated Lesion, Hyperplastic Polyp, Carcinoma, Adenoma, Non-Adenoma
Enrollment 1,178 participants
Start Date 2024-09-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-13